Chemence Inc. Company Profile

Background

Overview

Chemence Inc. is a global leader in the development, manufacturing, and distribution of specialty adhesives and sealants. Established in 1983 by founder Hugh V. Cooke, the company has grown to become a significant player in the chemical manufacturing industry, offering a diverse range of products tailored for industrial, consumer, and medical applications. With manufacturing facilities in Alpharetta, Georgia, USA, and Corby, Northamptonshire, UK, Chemence serves a global clientele, emphasizing innovation, quality, and customer-centric solutions.

Mission and Vision

Chemence's mission is to create bonds that last by providing high-quality adhesive solutions that meet the evolving needs of its customers. The company's vision is to be a pioneer in adhesive technology, delivering innovative products that enhance performance and reliability across various industries.

Primary Area of Focus

Chemence specializes in polymerizable technologies, focusing on adhesives and sealants that cure to form strong, durable bonds. Their product portfolio includes cyanoacrylate adhesives, anaerobic adhesives, UV curing resins, and liquid photopolymers, catering to sectors such as automotive, consumer electronics, medical devices, and cosmetics.

Industry Significance

As a privately held company, Chemence has established itself as a key supplier of specialty adhesives and sealants, holding over 60 patents for products and processes. Its commitment to innovation and quality has earned it partnerships with major corporations, including 3M, Bostik, and Bondo, and recognition as a primary sealant supplier to British Gas.

Key Strategic Focus

Core Objectives

• Innovation: Continuously developing advanced adhesive technologies to meet diverse customer needs.

• Quality Assurance: Maintaining high standards through ISO certifications and Good Manufacturing Practices.

• Global Expansion: Strengthening market presence through strategic acquisitions and facility expansions.

Specific Areas of Specialization

• Medical Adhesives: Developing tissue adhesives for wound closure and embolization procedures.

• Industrial Adhesives: Providing solutions for automotive assembly, electronics manufacturing, and construction.

• Cosmetic Adhesives: Offering nail glues, resins, and UV curing nail products for the beauty industry.

Key Technologies Utilized

• Cyanoacrylate Adhesives: Fast-curing adhesives used in medical and industrial applications.

• UV Curing Resins: Light-activated adhesives for rapid bonding in various manufacturing processes.

• Liquid Photopolymers: Materials used in flexographic printing and photopolymer plate making.

Primary Markets Targeted

• Medical Devices: Supplying adhesives for surgical procedures and wound care.

• Automotive Industry: Providing bonding solutions for vehicle assembly.

• Consumer Electronics: Offering adhesives for device assembly and component bonding.

• Cosmetics: Supplying nail adhesives and UV curing products for the beauty sector.

Financials and Funding

Funding History

Chemence remains a privately held company and has not publicly disclosed detailed funding histories or financial statements. The company has achieved significant growth through organic development and strategic acquisitions, including the purchase of Supreme Resources' electronics adhesives business in 2018.

Recent Funding Rounds

Specific details regarding recent funding rounds are not publicly available.

Notable Investors

As a privately held entity, Chemence has not disclosed information about its investors.

Intended Utilization of Capital

Chemence has utilized capital to expand its manufacturing capabilities, enhance research and development efforts, and acquire complementary businesses to strengthen its product portfolio and market presence.

Pipeline Development

Key Pipeline Candidates

• Exofin® High Viscosity Tissue Adhesive: A topical skin adhesive with the highest viscosity formulation in the industry, received FDA approval in 2018.

• Exofin® Precision Pen: A medical device for wound closure, offering greater versatility and precision, received FDA clearance in 2022.

• Exofin Fusion® Skin Closure System: A redesigned system with a curved mesh design to enhance wound closure and healing, launched in 2021.

Stages of Clinical Trials or Product Development

Chemence's medical products have progressed through various stages of development, with key products receiving FDA approval and clearance, indicating successful clinical trials and regulatory processes.

Target Conditions

• Exofin® High Viscosity Tissue Adhesive: Intended for wound closure in surgical and emergency settings.

• Exofin® Precision Pen: Designed for precise wound closure in medical procedures.

• Exofin Fusion® Skin Closure System: Aimed at improving wound healing and patient outcomes.

Relevant Timelines for Anticipated Milestones

Chemence continues to focus on product development and market expansion, with recent milestones including the launch of new products and facility expansions.

Technological Platform and Innovation

Proprietary Technologies

• Exofin® Tissue Adhesives: A line of medical adhesives for wound closure and embolization.

• Krylex® Adhesive Line: An industrial adhesive line developed in-house and relaunched for industrial manufacturing.

Significant Scientific Methods

• Polymerization Chemistry: Utilizing polymerizable technology to create adhesives that cure into solids, ensuring strong and durable bonds.

• UV Curing Technology: Employing light-activated curing processes for rapid bonding in manufacturing applications.

Leadership Team

Key Executive Profiles

• James Cooke: Chief Executive Officer (CEO)

• Professional Background: Over 30 years of experience in the chemical manufacturing industry, leading Chemence's strategic direction and growth initiatives.

• Key Contributions: Spearheaded the expansion into medical adhesives and the acquisition of Supreme Resources' electronics adhesives business.

• Michael Pomykala: Vice President of Technology

• Professional Background: Extensive experience in research and development within the chemical industry.

• Key Contributions: Led the establishment of the Chemence Center of Excellence, enhancing the company's R&D capabilities.

Competitor Profile

Market Insights and Dynamics

The specialty adhesives and sealants market is characterized by continuous innovation, regulatory compliance, and a focus on sustainability. Key trends include the development of environmentally friendly products and the expansion into emerging markets.

Competitor Analysis

• Dymax Corporation: Specializes in light-curable adhesives and coatings, serving industries such as medical devices and electronics.

• Chase Corporation: Produces protective materials, including adhesives and coatings, primarily for industrial applications.

• Hernon Manufacturing: Offers adhesives, sealants, and dispensing equipment for various industries.

Strategic Collaborations and Partnerships

Chemence has formed strategic partnerships to enhance its product offerings and market reach, including collaborations with major corporations and acquisitions to expand its technology portfolio.

Operational Insights

Chemence's focus on innovation, quality assurance, and global expansion positions it competitively in the specialty adhesives market, enabling it to meet diverse customer needs across various industries.

Strategic Opportunities and Future Directions

Strategic Roadmap

• Product Innovation: Continuing to develop advanced adhesive technologies to meet evolving market demands.

• Market Expansion: Entering new geographic regions and industries to broaden the customer base.

• Sustainability Initiatives: Implementing environmentally friendly manufacturing processes and products.

Future Business Directions

Chemence aims to leverage its technological expertise and global presence to drive growth, focusing on high-performance adhesives and sealants that address the specific needs of its diverse clientele.